MUC5AC and cholangiocarcinoma: Once identified GCA, GCDCA, TCA, and TCDCA as the best biomarkers associated with CCA we investigated their effect on human primary cholangiocytes and HuH28, a well-known CCA cellular model [42,43], with the purpose of assessing changes in MUC5AC expression.